Vivos Therapeutics Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
268
- Stock Symbol
-
VVOS
- Investments
-
9
- Share Price
-
$0.05
- (As of Friday Closing)
Vivos Therapeutics General Information
Description
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Contact Information
Website
www.vivos.comCorporate Office
- 9137 South Ridgeline Boulevard
- Suite 210
- Highlands Ranch, CO 80129
- United States
Corporate Office
- 9137 South Ridgeline Boulevard
- Suite 210
- Highlands Ranch, CO 80129
- United States
Vivos Therapeutics Timeline
Vivos Therapeutics Stock Performance
As of 20-Nov-2026, Vivos Therapeutics’s stock price is $0.05. Its current market cap is $1.83M with 33.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $0.06 | $0.05 - $2.69 | $1.83M | 33.8M | 14.2M | -$1.35 |
Vivos Therapeutics Financials Summary
As of 30-Sep-2026, Vivos Therapeutics has a trailing 12-month revenue of $20.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 16,636 | 27,657 | 20,598 | 17,686 |
| Revenue | 20,532 | 17,443 | 15,031 | 13,801 |
| EBITDA | (20,242) | (19,921) | (10,555) | (12,962) |
| Net Income | (22,062) | (21,230) | (11,136) | (13,583) |
| Total Assets | 22,856 | 25,152 | 15,284 | 10,730 |
| Total Debt | 5,989 | 13,502 | 1,512 | 1,995 |
Vivos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vivos Therapeutics Comparisons
Industry
Financing
Details
Vivos Therapeutics Competitors (5)
One of Vivos Therapeutics’s 5 competitors is Wellell, a Venture Capital-Backed company based in New Taipei, Taiwan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wellell | Venture Capital-Backed | New Taipei, Taiwan | ||||
| Nyxoah | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Inspire Medical Systems | Formerly VC-backed | Golden Valley, MN | ||||
| Somnics | Venture Capital-Backed | Zhubei, Taiwan | ||||
| SomnoMed | Formerly PE-Backed | Sydney, Australia |
Vivos Therapeutics Patents
Vivos Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250256056-A1 | Methods, systems, and devices for the treatment of stress disorders | Pending | 09-Feb-2024 | ||
| US-20240428920-A1 | Orofacial myofunctional therapy methods and systems | Pending | 25-Jan-2022 | ||
| WO-2023147341-A1 | Orofacial myofunctional therapy methods and systems | Inactive | 25-Jan-2022 | ||
| US-11723790-B2 | Vibrational oral appliance with mandibular advancements | Active | 09-Nov-2021 | ||
| US-12048608-B2 | Vibrational oral appliance with mandibular advancements | Active | 09-Nov-2021 | A61C7/008 |
Vivos Therapeutics Signals
Vivos Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vivos Therapeutics Investments & Acquisitions (9)
Vivos Therapeutics’s most recent deal was a Corporate with SOD Sciences for . The deal was made on 19-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SOD Sciences | 19-Oct-2026 | Corporate | Clinics/Outpatient Services | ||
| The Sleep Center of Nevada | 10-Jun-2025 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Advanced Facialdontics (Product Rights and Intellectual Property is Based in Littleton, Colorado) | 01-Mar-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Lyon Management and Consulting (Medical Billing and Practice Management Software) | 14-Apr-2021 | Corporate Asset Purchase | Buildings and Property | ||
| MyoCorrect | 29-Mar-2021 | Merger/Acquisition | Other Healthcare Services |
Vivos Therapeutics ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
36.73 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Vivos Therapeutics Exits (1)
Vivos Therapeutics’s most recent exit was on 01-Jul-2018 from TMJ & Sleep Therapy Centre of Utah. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| TMJ & Sleep Therapy Centre of Utah | 01-Jul-2018 | Completed |
|
Vivos Therapeutics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Apex Dental Sleep Lab | La Mesa, CA | 2017 | |
| The Sleep Center of Nevada | Las Vegas, NV | 2008 |
Vivos Therapeutics FAQs
-
When was Vivos Therapeutics founded?
Vivos Therapeutics was founded in 2013.
-
Where is Vivos Therapeutics headquartered?
Vivos Therapeutics is headquartered in Highlands Ranch, CO.
-
What is the size of Vivos Therapeutics?
Vivos Therapeutics has 268 total employees.
-
What industry is Vivos Therapeutics in?
Vivos Therapeutics’s primary industry is Therapeutic Devices.
-
Is Vivos Therapeutics a private or public company?
Vivos Therapeutics is a Public company.
-
What is Vivos Therapeutics’s stock symbol?
The ticker symbol for Vivos Therapeutics is VVOS.
-
What is the current stock price of Vivos Therapeutics?
As of 20-Nov-2026 the stock price of Vivos Therapeutics is $0.05.
-
What is the current market cap of Vivos Therapeutics?
The current market capitalization of Vivos Therapeutics is $1.83M.
-
What is Vivos Therapeutics’s current revenue?
The trailing twelve month revenue for Vivos Therapeutics is $20.5M.
-
Who are Vivos Therapeutics’s competitors?
Wellell, Nyxoah, Inspire Medical Systems, Somnics, and SomnoMed are competitors of Vivos Therapeutics.
-
What is Vivos Therapeutics’s annual earnings per share (EPS)?
Vivos Therapeutics’s EPS for 12 months was -$1.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process